General Information of Drug (ID: DMG57EV)

Drug Name
SBG
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 3 [1]
Cross-matching ID
TTD ID
D0V6IM

References

1 ClinicalTrials.gov (NCT00632008) Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers. U.S. National Institutes of Health.